Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 DBMR VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.1.1 POLITICAL FACTORS:
4.1.2 ECONOMIC FACTORS:
4.1.3 SOCIAL FACTORS:
4.1.4 TECHNOLOGICAL FACTORS:
4.1.5 LEGAL FACTORS:
4.1.6 ENVIRONMENTAL FACTORS:
4.2 PORTER’S FIVE FORCES
4.3 VENDOR SELECTION CRITERIA
5 DYNAMICS OF RAW MATERIAL PREFERENCES
5.1 PLASTIC AND POLYMERS:
5.1.1 HDPE (HIGH-DENSITY POLYETHYLENE):
5.1.2 LDPE (LOW-DENSITY POLYETHYLENE):
5.1.3 PET (POLYETHYLENE TEREPHTHALATE):
5.1.4 PVC (POLYVINYL CHLORIDE):
5.1.5 PP (POLYPROPYLENE):
5.1.6 COC (CYCLIC OLEFIN COPOLYMER):
5.2 GLASS:
5.2.1 TYPE IV-NP (GENERAL PURPOSE SODA LIME GLASS):
5.2.2 TYPE I (BOROSILICATE GLASS):
5.2.3 TYPE III (REGULAR SODA-LIME GLASS):
5.2.4 TREATED SODA LIME GLASS:
5.3 METAL:
5.3.1 TIN:
5.3.2 IRON:
5.3.3 ALUMINIUM:
5.3.4 LEAD:
5.4 PAPER AND BOARD:
5.4.1 SOLID BOARD:
5.4.2 CHIPBOARD:
5.4.3 CARDBOARD:
5.4.4 FIBER BOARD:
5.5 RUBBER:
5.5.1 NATURAL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING:
5.5.2 NEOPRENE RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING:
5.5.3 BUTYL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING:
6 PARTNERSHIP DETAILS
7 TECHNOLOGICAL ADVANCEMENTS
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 STRONG SPENDING TOWARDS PHARMA INDUSTRY
8.1.2 IMPACT OF COMPLEX DRUG FORMULATIONS AND SPECIALIZED PACKAGING NEEDS
8.1.3 IMPACT OF REGULATORY COMPLIANCE AND QUALITY ASSURANCE DEMANDS
8.2 RESTRAINTS
8.2.1 AVAILABILITY OF CHOICE OF IN-HOUSE PACKAGING FROM MANUFACTURERS
8.2.2 SUSTAINABILITY CONCERNS DUE TO USAGE OF PLASTICS IN PACKAGING MATERIALS
8.3 OPPORTUNITIES
8.3.1 TECHNOLOGICAL ADVANCEMENTS IN PACKAGING MACHINERY AND MATERIALS
8.3.2 RISING NEED FOR BIOPHARMACEUTICAL COLD CHAIN PACKAGING
8.4 CHALLENGE
8.4.1 DIVERSE CONCERNS RELATED TO OPERATIONAL HURDLES
9 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: BY REGION
9.1 OVERVIEW
9.2 EUROPE
9.3 NORTH AMERICA
9.4 SOUTH AMERICA
9.5 ASIA-PACIFIC
9.6 MIDDLE EAST & AFRICA
10 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: EUROPE
10.3 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 ABBVIE INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 SERVICE PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 PCI PHARMA SERVICES
12.2.1 COMPANY SNAPSHOT
12.2.2 COMPANY SHARE ANALYSIS
12.2.3 SERVICE PORTFOLIO
12.2.4 RECENT DEVELOPMENTS
12.3 NELIPAK CORPORATION
12.3.1 COMPANY SNAPSHOT
12.3.2 COMPANY SHARE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENTS
12.4 SHARP SERVICES, LLC
12.4.1 COMPANY SNAPSHOT
12.4.2 COMPANY SHARE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENTS
12.5 APHENA PHARMA SOLUTIONS
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 SERVICE PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 AMERIPAC
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 ASSEMBLIES UNLIMITED, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 SERVICE PORTFOLIO
12.7.3 RECENT DEVELOPMENT
12.8 JONES HEALTHCARE GROUP
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 REED-LANE
12.9.1 SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.1 ROPACK INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 SEPHA
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENTS
12.12 SILGANUNICEP
12.12.1 COMPANY SNAPSHOT
12.12.2 SERVICE PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 STERNMAID GMBH & CO. KG
12.13.1 COMPANY SNAPSHOT
12.13.2 SERVICE PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 TJOAPACK
12.14.1 COMPANY SNAPSHOT
12.14.2 SERVICE PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 TRIPAK PHARMACEUTICALS
12.15.1 COMPANY SNAPSHOT
12.15.2 SERVICE PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 WASDELL PACKAGING GROUP
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Figure
FIGURE 1 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: SEGMENTATION
FIGURE 2 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: APPLICATION COVERAGE GRID
FIGURE 10 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET, WHILE ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 13 STRONG SPENDING TOWARDS PHARMA INDUSTRY IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET IN THE FORECAST PERIOD
FIGURE 14 THE PRIMARY PACKAGING SYSTEM SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE OF THE GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET IN 2023 AND 2030
FIGURE 15 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR THE GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET IN THE FORECAST PERIOD
FIGURE 16 VENDOR SELECTION CRITERIA
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET
FIGURE 18 FDI INFLOWS IN DRUGS & PHARMACEUTICALS ACTIVITIES
FIGURE 19 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 20 EUROPE CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 21 NORTH AMERICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 22 SOUTH AMERICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 23 ASIA-PACIFIC CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 24 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2022)
FIGURE 25 GLOBAL CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2022 (%)
FIGURE 26 EUROPE CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2022 (%)
FIGURE 27 NORTH AMERICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2022 (%)
FIGURE 28 ASIA-PACIFIC CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2022 (%)
